CVI Holdings’s Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock ARCK Stock Holding History

CVI Holdings’s Portfolio ARCK Stock Details ARCK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-87,759	Closed	-$887K	–	742
2022 Q3	$887K	Hold	87,759	–	–	0.07%	346
2022 Q2	$880K	Hold	87,759	–	–	0.06%	371
2022 Q1	$878K	Buy	87,759 +5,710	+7%	+$57.1K	0.06%	405
2021 Q4	$816K	Buy	+82,049	New	+$814K	0.05%	393

Other funds holding ARCK

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CVI Holdings's ARCK Position: Q4 2022 in Review

CVI Holdings sold out of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) in Q4 2022, closing a stake of 87,759 shares — an estimated $887K sold.

CVI Holdings first reported a position in ARCK in Q4 2021 and held it in 4 quarters. The position peaked at $887K in Q3 2022. 2 funds tracked by Wall St. Rank hold ARCK as of Q4 2022.

CVI Holdings reported no remaining Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position as of Q4 2022 after selling out during the quarter.
CVI Holdings sold 87,759 Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock shares in Q4 2022, an estimated $887K.
CVI Holdings first reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in Q4 2021 and held it in 4 quarters.
CVI Holdings's Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position peaked at $887K in Q3 2022.
2 funds tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock as of Q4 2022.

Based on CVI Holdings's 13F filing for Q4 2022, filed 14 Feb 2023.